Stackhaus Research is a US-based online supplier of research-grade peptides and compounds for laboratory and preclinical use. We specialize in synthetic peptides, including BPC-157, Tesamorelin, AOD-9604, and more. All compounds are produced via solid-phase peptide synthesis (SPPS) and verified through third-party HPLC and mass spectrometry testing. Every batch ships with a Certificate of Analysis documenting purity and composition. Stackhaus Research is committed to providing the scientific research community with reliable, high-purity compounds for legitimate laboratory investigation. All products are strictly for research use only and are not intended for human consumption.

At Treasure Coast Solutions, LLC is based in Jensen Beach, FL and provides research chemicals and laboratory supplies for scientific and research use. We focus on quality, consistency, and reliability by ensuring our products are independently third-party tested. Our goal is to support researchers with dependable materials that meet high standards of accuracy and performance. With a commitment to professionalism and strict quality control, we serve the local research community with trusted supplies and responsive service.

ExaVeyra Sciences is a Miami Beach-based B2B wholesale supplier of regenerative medicine products for licensed healthcare practitioners. We supply biomolecular signaling vesicles, peptides, PRP kits, and medical devices to NPI-verified clinics, med spas, dermatology practices, orthopedic offices, and functional medicine providers across the United States. Our sourcing partners operate under 503A/503B compounding pharmacy frameworks with full cGMP compliance. Every order ships with a Certificate of Analysis, cold-chain temperature monitoring, and lot-specific documentation. Founded by an organic chemist with a background in nucleotide process chemistry, ExaVeyra brings scientific rigor to a market that has historically lacked it.

Covalon researches, develops and commercializes new healthcare technologies that help save lives around the world. Covalon’s patented technolo¬gies, products and services address the advanced healthcare needs of medical device companies, healthcare providers and individual consumers. Covalon’s technologies are used to prevent, de¬tect and manage medical conditions in specialty areas such as wound care, tissue repair, infection control, disease management, medical device coatings and biocompatibility.

The company was founded in 1999 as an integrated biopharmaceutical company with a focus on development and manufacturing as well as having expertise in preclinical and clinical development, formulation optimization, and cGMP manufacturing of biopharmaceutical products and medical devices. From its early beginnings, the company’s growth was fueled through grants and contracts from both industry and several U.S. Government (USG) agencies (NIH, DoD, NCI, BARDA). Today, the company has grown to over 185 employees located in several offices across the U.S. On March 30, 2013, the Department of Defense (DoD) awarded the company and its team of partners and collaborators a contract to provide all of the core services necessary to establish a Medical Countermeasures Advanced Development and Manufacturing (MCM ADM) facility dedicated to meeting the specific needs of the DoD. The 10-year, $400+ million contract had a base period goal for the construction of an 183,000-square-foot, state-of-the-art, BSL-3, single-use facility that the company now occupies and operates. Ology Bio recently developed and acquired proprietary platform technologies that are used in the production of biologic products including proteins, monoclonal antibodies, and vaccines. Ology Bioservices, Inc. has positioned itself to be one of the leading Contract Development and Manufacturing Organizations (CDMO) on a global level.

Our robotic solutions can help automate your manufacturing processes, increase efficiency, and improve safety. Let us help you take your business to the next level with robotics. Our quantum computing solutions can help you solve problems that are impossible for classical computers, improve security, and advance research in science and technology. Let us help you explore the possibilities of quantum computing.

Clinartis leverages access to the best clinical researchers in the United States, the Baltics and Eastern Europe. Clinartis is entirely focused on delivering projects through a collaborative and personalized approach. Clinartis' comprehensive clinical service offering includes the following: Project Management Regulatory Affairs Clinical Services Medical Affairs Data Management and Analysis

Mack Bio is a maverick in the biotechnology industry. We are a integral part of a fast growing and ever evolving industry - Nanomedicine. Nanomedicine is defined as a device or pharmaceutical on the scale of 1 nm to 300nm (nm - one billionth of a meter) in size. At this scale, we can interact one on one with bacteria, viruses, DNA, cells and tissues. Nano sized objects have always existed in nature but until recently, we as researchers, have learned to visualize and control these sizes of particles. From a financial standpoint, nanomedicine is currently a $212B market world-wide and is estimated to double in market growth and reach $ 528B by late 2019. Some other companies involved directly in nanomdedicine today include: Ablynx NV, Celgene Corporation, Abraxis Bioscience Inc., Mallinckrodt PLC, GE Healthcare, Qiagen NV, Combimatrix Corp, Merck & Co. Inc., Pfizer Inc., Nanosphere, Inc., Arrowhead Research, and Teva Pharmaceutical Industries Ltd. Mack Bio's mission is two fold. Our first goal is to provide a fast, efficient and safe pathway from concept to approval of new medical products. We are a new evolution of a focused and rapidly adapting developer of nanotechnology for medicine. We are driven to create design of medical technology based on nano and micron scale. Whether nanoparticles, micron printed systems or nano wave length light. We believe the solutions in medicine tomorrow will be based in this scale. Our second focus is to partner with other biotech companies, designers and inventors in order to raise research funding and create synergy between these alliances. We offer a platform to fund new concepts as well as partner to fund clinical trials. Based on this synergy, we aspire to propel our strategic partners to the next level of development. Our Six Biologically Based Corporate Attributes: - Adaptation - Redundancy - Diversity - Modularity - Prudence - Embeddedness Mack Bio is a dynamic corporation offering the flexibility to react to the ever changing landscape of the medical field. What would normally take years to complete takes us months. We are already working on several novel projects with several partners to create real solutions for the both medical device and OTC pharmaceuticals markets.